Core Viewpoint - Neogen Corporation is facing a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, with claims that the company and its executives misled investors regarding the integration of its business with 3M's Food Safety Division and the financial implications of this merger [1][3][4]. Group 1: Class Action Details - The class action lawsuit is titled "Operating Engineers Construction Industry and Miscellaneous Pension Fund v. Neogen Corporation" and covers purchasers of Neogen common stock from January 5, 2023, to June 3, 2025 [1]. - Investors have until September 16, 2025, to seek appointment as lead plaintiff in the lawsuit [1]. - The lawsuit alleges that Neogen's executives made false statements about the progress of the integration with 3M and downplayed inefficiencies that arose during this process [3]. Group 2: Financial Performance and Impact - On January 10, 2025, Neogen reported a significant GAAP net income loss due to a $461 million non-cash goodwill impairment charge related to the 3M acquisition, leading to a more than 5% drop in stock price [4]. - In the third quarter of 2025, Neogen reported a loss of $11 million, a significant increase from a loss of $2 million the previous year, and a revenue decline of 3.4% to $221 million, attributed to integration issues [5]. - Following the announcement of expected EBITDA margin drop to the high teens from 22%, Neogen's stock price fell more than 17% [6].

SAN DIEGO, July 18, 2025 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Neogen Corporation (NASDAQ: NEOG) securities between January 6, 2023 and June 3, 2025. Neogen is a food safety company that manufactures and markets products and services dedicated to food and animal safety.For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.The Allegations: Robbins LLP is Inve ...

NEW YORK, June 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Neogen Corporation (“Neogen” or the “Company”) (NASDAQ: NEOG).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.    The investigation concerns whether Neogen and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On June 4, ...

LOS ANGELES, June 18, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Neogen Corporation (“Neogen” or the “Company”) (NASDAQ: NEOG) investors concerning the Company’s possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON NEOGEN CORPORATION (NEOG), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? On June 4, 2025, Neogen disclosed tha ...

NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Neogen Corporation (“Neogen” or the “Company”) (NASDAQ: NEOG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.    The investigation concerns whether Neogen and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On June 4, 20 ...

BENSALEM, Pa., June 17, 2025 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith continues its investigation on behalf of Neogen Corporation (“Neogen” or the “Company”) (NASDAQ: NEOG) investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN NEOGEN CORPORATION (NEOG), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal rights by ...

LOS ANGELES, June 16, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz continues its investigation of Neogen Corporation (“Neogen” or the “Company”) (NASDAQ: NEOG) on behalf of investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON NEOGEN CORPORATION (NEOG), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS.   What Is The Investigation About? On June 4, 2025, Neogen disclosed that, while its fourth quar ...

Core Viewpoint - The Schall Law Firm is investigating Neogen Corporation for potential violations of securities laws, particularly regarding misleading statements and undisclosed information that may have affected investors [1][2]. Group 1: Investigation Details - The investigation centers on whether Neogen issued false or misleading statements and failed to disclose critical information to investors [2]. - On June 4, 2025, Neogen acknowledged that its Q4 2025 financial results would be "materially approximate" to previous guidance but expected an EBITDA margin in the "high-teens," a significant decline from the prior quarter's margin of 22% [2]. - The company attributed this decline to "elevated inventory write-offs," which led to a 17.3% drop in Neogen's share price on the same day [2].

Summary of Neogen's Conference Call Company Overview - **Company**: Neogen Corporation - **Industry**: Food Safety and Animal Safety Testing - **Key Leadership**: CFO and COO Dave Namora presented the updates during the call [2][3] Core Business Segments - Neogen operates primarily in two segments: - **Food Safety Testing**: Represents approximately 65% of the overall portfolio, significantly increased due to the acquisition of 3M's food safety division [4][5] - **Animal Safety**: Focuses on disease prevention and care for production animals [6][7] Market Dynamics - The total addressable market (TAM) for food safety is growing, driven by: - Increasing food production demands - Growth of the middle class in emerging markets - Rising food safety concerns, including allergens and pathogens [8][9][10] - The company has experienced a slowdown in growth due to macroeconomic headwinds, particularly in the U.S. and uncertainties in global trade [14][29] Financial Performance - Q4 revenue is expected to align with previous guidance, with EBITDA margins projected in the high teens, impacted by transitory headwinds [13][14][22] - Inventory write-offs have been elevated, affecting gross margins, but these issues are expected to resolve in the coming quarters [24][25][27] - The company anticipates divesting its cleaners and disinfectants business (approximately $60 million in revenue) and genomics business (approximately $90 million in revenue) [37][38] Integration and Operational Challenges - The integration of the 3M acquisition is ongoing, with the petri film manufacturing line being the last major component to complete [19][43] - The company is focused on improving execution and operational efficiency to drive better results [12][20] Strategic Focus Areas - Neogen is concentrating on: - Growth acceleration and margin expansion - Completing the integration of the 3M acquisition - Enhancing product delivery and customer service [17][18][45] - The leadership team has undergone changes to better position the company for future growth [19][46] Risks and Opportunities - **Risks**: Successful completion of the petri film manufacturing project is critical; any delays could impact overall performance [55][56] - **Opportunities**: Establishing a solid operational foundation in fiscal 2026 could lead to growth momentum into fiscal 2027 [57] Conclusion - Neogen is navigating through integration challenges and market pressures but remains optimistic about its long-term growth potential in the food safety and animal safety sectors. The focus on operational improvements and strategic divestitures is expected to enhance profitability and market position moving forward [21][54][58]

Company Overview - Neogen is a global leader in food security, uniquely positioned to support a safe, sufficient, and sustainable food supply[6, 7] - The company's product offerings across Food Safety and Animal Safety platforms address global food security challenges[8] - Neogen has undergone a strategic shift of its portfolio towards Food Safety, with Food Safety accounting for 64% of revenue after combining with the former 3M Food Safety business[9, 10] Market and Growth Drivers - Neogen addresses large and growing markets with attractive long-term fundamentals, driven by trends like increasing food allergies, rising incomes in emerging markets, and increasing traceability requirements[15] - The company operates in the Food Safety market, estimated at $22 billion with a long-term growth rate of 6-8%, and the Animal Safety market, estimated at $55 billion with a long-term growth rate of 4-6%[15] - The company has significant opportunity to achieve long-term success in the high-growth Food Safety category[16] Financial Performance and Outlook - Preliminary view suggests Q4 FY25 revenue will materially approximate guidance, with adjusted EBITDA margin anticipated to be in the high-teens range[18] - The company estimates the annualized direct impact of current tariffs at approximately $5 million after supply actions, exemption waivers, and pricing[18] - The company anticipates ~$100M in Q1 FY '26 from portfolio actions to be used for debt paydown[19] Strategic Initiatives - Neogen is implementing a targeted improvement plan to accelerate Food Safety growth, complete the 3M FSD integration, reinvigorate innovation, and align the cost structure[19] - The company is simplifying and focusing on the most attractive end markets, with the Cleaners & Disinfectants divestiture signed in Q4 and a process underway for Genomics[19] - Neogen is undertaking actions to reduce net leverage below 30x and maintain ample liquidity[19]